Clinical Trial Update: An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Observational real-world Phase 2 study evaluating toripalimab plus TACE for extrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrahepatic Cholangiocarcinoma

Drugs mentioned

• TACE
• Toripalimab Injection (toripalimab)

Snippet

Sponsor: Xuhua Duan | Conditions: Extrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN